Pharming Group's legacy product RUCONEST posted a 10% year-over-year sales decline in Q2 2026 -- and PHAR shares fell 22% the day it was reported. Levi & Korsinsky is investigating potential securities law violations on behalf of PHAR shareholders. NEW YORK, July 31, 2026 /PRNewswire/ --...
Hence then, the article about pharming group investigation notice levi korsinsky notifies investors of pending investigation into pharming group phar was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Pharming Group Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Pharming Group (PHAR) )
Also on site :
- Kevin Warsh’s first big press conference shines a spotlight on confusion over how the Fed actually measures inflation
- Ractigen Therapeutics Announces U.S. FDA IND Clearance for First-in-Class saRNA Candidate RAG-1C to Treat Proliferative Vitreoretinopathy
- EA expect their $55 billion sale to Saudi Arabia and private equity firms to close next week, with "all regulatory approvals required" in place